Assessing device development and regulation for advanced innovation

SAN DIEGO, Va. - March 22, 2022 - PRLog -- As part of SMi's leading series of drug delivery device conferences, the 2022 event will provide insights into the rapidly accelerating market of combination product development with industry, device developer and regulatory perspectives.

The last year has seen major advances in device design and development with patient usability, ease of use and safety remaining at the forefront. This upcoming conference will assess the industry movement towards enabling self-administration through advanced device design, innovations in connectivity to aid the user, and the increasing importance of biologics and novel drug product considerations for device development. Furthermore, regulatory bodies and leaders from big pharma will give an international update on the fast-evolving industry landscape. As one of our most sought-after events, this conference is not to be missed.

This two-day agenda offers you peer-to-peer networking with Global Product Managers, Senior PFS Engineers, Device Testing Managers, Heads of Late-Stage PFS Development and many more.

Visit the website to find out more: http://www.prefilled-syringes-westcoast.com/

Benefits of attending:

• Discover the latest advances in innovative device design for user-centric drug delivery
• Assess evolving approaches to platforms for advanced combination product portfolios
• Uncover the key considerations to ensure optimal lifecycle management for drug delivery devices
• Explore how the industry is evolving with global developments including case studies of sustainable practices for drug delivery devices and the industry's role in mass vaccination campaigns
• Engage in interactive sessions reviewing the landscape of on-body injectors for large volume delivery and the role of connectivity for wearable devices

Chairs for 2022:

Tina Rees, Associate Director, Human Factors, Regeneron Pharmaceuticals

Natalie Abts, Head of Human Factors Engineering, Genentech

Featured 2022 speakers include:

• Sriman Banerjee, Head of Packaging Development & Commercial Device Engineering, Takeda
• Amin Sedighiamiri, Associate Director, Device Development, AstraZeneca
• James Wabby, Executive Director, Head of Regulatory Strategy, Emerging Technologies and Combination Products, Abbvie
• Khaudeja Bano, Executive Medical Director, Combination Product Safety Head, Amgen
• Rachel poker, Associate Director, Human Factors, AstraZeneca
• Kristina Li, Sr. Engineer II, Technical Development, Biogen
• sujani Nannapaneni, Human Factors Principal Research Engineer, Combination Product Development, Abbvie

Visit the website to find out more: http://www.prefilled-syringes-westcoast.com/